Comisia Europeană a semnat un contract cadru de achiziţie cu compania farmaceutică Eli Lilly pentru un tratament cu anticorpi monoclonali pentru pacienţii COVID-19, conform unui comunicat de presă publicat marţi pe site-ul executivului european, relatează Agerpres.
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/10/hearings_hearings_stella_kyriakides_cyprus___health_48828011992_75967900-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2012/04/pfizer_0123_36610900.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2013/08/1364810954_novartis_15_28543900-730x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2013/08/eli_lilly_99301800.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2012/04/steag_romania3_62936800.jpg)
